These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Electrostatic characteristics of pharmaceutical solids and packaging materials I. Design of testing equipment and preliminary findings. Lachman L; Lin SL J Pharm Sci; 1968 Mar; 57(3):504-10. PubMed ID: 4231784 [No Abstract] [Full Text] [Related]
23. [Determination of the power of galenic-pharmaceutical industries--important stage in the planning of their production]. Vasil'chenko OG Farm Zh; 1970; 25(4):70-5. PubMed ID: 5487996 [No Abstract] [Full Text] [Related]
24. Development of a new concept for time/pressure filling. Yoshida S PDA J Pharm Sci Technol; 2003; 57(2):126-30. PubMed ID: 14674514 [No Abstract] [Full Text] [Related]
28. Technical report # 39: cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Parenteral Drug Association. PDA J Pharm Sci Technol; 2005; 59(3 Suppl TR39):1-12. PubMed ID: 16313059 [No Abstract] [Full Text] [Related]
29. [Advances in the field of galenics (1965 to 1967)]. Chalabala M; Malý J; Burelová A Pharmazie; 1969 Feb; 24(2):65-86. PubMed ID: 4891843 [No Abstract] [Full Text] [Related]
30. Process simulation testing for aseptically filled products. Parenteral Drug Association. PDA J Pharm Sci Technol; 1996; 50 Suppl 1():S1-16. PubMed ID: 9038088 [No Abstract] [Full Text] [Related]
31. [Mechanization of the process of pulverization and mixing of hard pharmaceutical compounds]. Islamgulov MKh Farmatsiia; 1967; 16(2):68-71. PubMed ID: 5611776 [No Abstract] [Full Text] [Related]
32. Optimising the therapeutic trinity of active ingredient, delivery system and functional packaging. Sam T J Control Release; 2003 Feb; 87(1-3):153-7. PubMed ID: 12618031 [TBL] [Abstract][Full Text] [Related]
33. Focus on vial sterility. Eggleston M Infect Control; 1984 Apr; 5(4):163-4. PubMed ID: 6562086 [No Abstract] [Full Text] [Related]
34. [Velocity of dissolution of the active principles of various pharmaceutic forms evaluated by different apparatuses]. Ceschel GC; Fontani F Boll Chim Farm; 1974 Apr; 113(4):260-6. PubMed ID: 4850114 [No Abstract] [Full Text] [Related]
35. [New formulations in dermatology]. Fredon L; Mallard C Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S30-6. PubMed ID: 17563712 [No Abstract] [Full Text] [Related]
36. First, do no harm: single-use/single-dose vials. Neonatal Netw; 2013; 32(3):223-4. PubMed ID: 23807963 [No Abstract] [Full Text] [Related]
37. [Possibility of long-term storage of tablet-form preparations in plastic tubes]. Malakhova ZN; Artem'ev AI Farmatsiia; 1976; 25(6):49-52. PubMed ID: 1001509 [No Abstract] [Full Text] [Related]
38. Comment to "The pharmacopeial evolution of Intralipid injectable emulsion in plastic containers: from a coarse to a fine emulsion". Ellborg A; Ferreira D; Mohammadnejad J; Wärnheim T Int J Pharm; 2010 Jun; 392(1-2):198-200. PubMed ID: 20347944 [TBL] [Abstract][Full Text] [Related]
39. [The role of drug industry in the pharmaceutical administration of the RSFSR]. Voloshin ME Farmatsiia; 1970; 19(4):7-11. PubMed ID: 5488027 [No Abstract] [Full Text] [Related]
40. [Quantitative determination of essential oil in galenic preparations and drug mixtures]. Vaĭsman GA; Osadchuk RG Farm Zh; 1969; 24(1):34-9. PubMed ID: 5782284 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]